作者: George William Farr , Marc F. Pelletier , Paul Robert Mcguirk , Steven Williams
DOI:
关键词:
摘要: The present invention relates to the use of selective aquaporin inhibitors, e.g., aquaporin-4 or aquaporin-2, certain phenylbenzamide compounds, for prophylaxis, treatment and control aquaporin-mediated conditions, glioblastoma ovarian hyperstimulation syndrome. provides, inter alia, methods treating controlling a disease condition mediated by an aquaporin, diseases conditions water imbalance other diseases.